Posted in | News

Crosslinx Transit Solutions Named Preferred Proponent for Eglinton Crosstown Light Rail Transit Project

Infrastructure Ontario and Metrolinx have named Crosslinx Transit Solutions (CTS)— a consortium of equal share partners ACS Infrastructure Canada, Aecon, EllisDon, and SNC-Lavalin— the preferred proponent to design, build, finance, and maintain the Eglinton Crosstown Light Rail Transit (LRT) project using the Alternative Financing and Procurement (AFP) model.

A significant part of Metrolinx's regional transportation plan, the ground-breaking Eglinton Crosstown LRT project will provide fast and reliable travel along Eglinton Avenue; integrate transit services; and create thousands of design and construction jobs.

The 19-kilometre project will run east-west on Eglinton Avenue between Mount Dennis (Weston) and Kennedy Station— one of Toronto's major travel arteries. The scope of work will include 25 stations and stops that link to bus routes; three subway stations; various GO Transit lines; and a 10.2-kilometre underground portion between Keele Street and Laird Drive. In addition, CTS will deliver a 22,500-square metre maintenance and storage facility at the western end of the LRT line; oversee the procurement and implementation of all systems, including the train control system; and construct third-party infrastructure for a number of local stakeholders, including the City of Toronto.

"EllisDon is ready to take on the largest P3 project in our company's history, and in the history of Canada," said Geoff Smith, EllisDon President and CEO. "The Eglinton Crosstown LRT project is a game-changer for the city of Toronto, one that will strengthen the region and improve the quality of life of thousands of commuters."

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.